CAMO will fund one-year research fellowships to strengthen Canada’s capacity in medical oncology research and training. Awards support solid-tumour projects across basic, translational, clinical, epidemiology, educational research, population health, and health outcomes domains. Two additional priority fellowships are offered in lung/neuroendocrine cancers and in less-researched breast cancer subtypes.
Eligibility Criteria:
-
Canadian citizen or landed immigrant.
-
MD and FRCPC in Internal Medicine.
-
In final year of a Royal College–certified Medical Oncology training program in Canada; CAMO will also consider first-year fellows seeking up to one additional year.
-
Associate member of CAMO (membership free).
-
Research must be in solid tumour malignancies.
-
Supervisor membership requirement: at least one named supervisor must be an active CAMO member in good standing (applications without this are ineligible).
-
Projects may be conducted within or outside Canada.
Funding Details:
-
Total per fellowship: up to $80,000 for 1 year.
-
Stipend: up to $75,000.
-
Research allowance: $5,000.
-
Selection prioritizes scientific merit, feasibility, originality, translatability to patient care and outcomes, and project quality irrespective of host location.
- Two specific awards in addition to the general CAMO fellowship:
-
Boehringer Ingelheim Canada Ltd/CAMO Fellowship in Lung Cancer and Neuroendocrine Cancers.
-
K. Jill Rigby Foundation/CAMO Fellowship for less-researched breast cancer subtypes (e.g., triple negative, lobular, ER-negative HER2-low, histiocytic, other rare histologies).
-
Deadline:
- November 21, 2025 at 5:00 p.m. Eastern Time.
-
Confirmation of receipt sent within 3 business days.
-
Funding decision by December 23, 2025.
-
Announcement to CAMO membership in early 2026.
Where to Go For Further Information:
- Program details.
- Send completed applications by email to [email protected].